A study of depressed individuals found that an eight‐week treatment with selective serotonin reuptake inhibitors (SSRIs) ...
MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...
Specific protein receptors in the brain play a vital role in how neurons slow down or stop firing, making them targets for many disorders. Researchers have now constructed a detailed structural ...
One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...
Scientists think ketamine relieves depression and anxiety by altering GluN1-2B-2D’s movements, but the effects can vary ...
A new study shows that enhancing activity of a specific component of 'NMDA' receptors normalizes protein synthesis, neural activity and seizure susceptibility in the hippocampus of fragile X lab mice.
Northwestern University researchers have identified structural features in engineered cell receptors that correlate with variations in receptor function.
Using protein structure prediction tools, researchers have uncovered receptor structure-function relationships to improve ...
New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback